|
Agilent technologies
bluescript ii k/s− factor viii cloning vector ![]() Bluescript Ii K/S− Factor Viii Cloning Vector, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bluescript+ii+k/pmc03346119-158-4-13 Average 90 stars, based on 1 article reviews
bluescript ii k/s− factor viii cloning vector - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Agilent technologies
bluescript ii k/s factor viii cloning vector ![]() Bluescript Ii K/S Factor Viii Cloning Vector, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bluescript+ii+k/10__1074_slash_jbc__m111__333948-53-4-13 Average 90 stars, based on 1 article reviews
bluescript ii k/s factor viii cloning vector - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Agilent technologies
bluescript ii k(2) vector ![]() Bluescript Ii K(2) Vector, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/bluescript+ii+k/pm10094865-66-7-11 Average 90 stars, based on 1 article reviews
bluescript ii k(2) vector - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Journal: The Journal of Biological Chemistry
Article Title: Sequences Flanking Arg 336 in Factor VIIIa Modulate Factor Xa-catalyzed Cleavage Rates at this Site and Cofactor Function
doi: 10.1074/jbc.M111.333948
Figure Lengend Snippet: Thrombogram for WT (solid line), 336(P4-P3′)372 (dashed line), 336(P4-P3′)740 (dotted line), 336(P4-P3′)562 (double line), and R336Q (×) FVIII variants. Reactions were run using 1 nm factor VIII, 0.15 pm recombinant tissue factor, and 4 μm phospholipid and thrombin generation in plasma was determined through calibrated automated thrombography as described under “Experimental Procedures.” Experiments were performed at least three times with mean ± S.D. within 20%.
Article Snippet: Mutants were introduced into
Techniques: Recombinant